查詢結果分析
來源資料
相關文獻
- 以鴿高病原性新城病病毒(NDV)株抗原製成不活化疫苗強化幼鴿對NDV之免疫保護力
- 新城病(Newcastle disease, ND)不活化疫苗之保護劑量試驗
- 熱休克蛋白70可增進融合在PTD-J domain上之NDV HN抗原基的免疫原性
- 新城病(Newcastle disease, ND)不活化疫苗之保護劑量試驗
- 瑞寶基因股份有限公司--新城病毒不活化疫苗種毒株之篩選及與野外毒株抗原性及交叉保護性分析
- 含多套數CpG模組質體應用於禽類疫苗之免疫佐劑效力
- 新城病不活化疫苗檢驗標準評析
- 禽用疫苗之CpG DNA佐劑
- 新城病血清學的疑問
- HVT-ND新城病載體疫苗『維特靈Vectormune® ND』--對抗頑強老敵人的新武器
頁籤選單縮合
題 名 | 以鴿高病原性新城病病毒(NDV)株抗原製成不活化疫苗強化幼鴿對NDV之免疫保護力=Improved Protection for Young Pigeons with Inactivated Newcastle Disease Virus (NDV) Vaccine Prepared from Highly Virulent NDV Isolates |
---|---|
作 者 | 林茂勇; 梁文榮; 沈漢彥; 黃兆銓; 游信偉; 柯冠銘; | 書刊名 | 臺灣獸醫學雜誌 |
卷 期 | 31:4 民94.12 |
頁 次 | 頁247-252 |
分類號 | 437.77 |
關鍵詞 | 新城病; 鴿; 疫苗; Newcastle disease; Pigeon; Vaccine; |
語 文 | 中文(Chinese) |
中文摘要 | 選對臺灣10個鴿群之164隻賽鴿血清可檢出較高血球抑制凝集反應(hemagglutination-inhibition;HI)拉體力價幾何平均值(geometric mean titer;GMT)和變異係數(coefficient variation;CV)值較高的4株第Ⅶ型WNDV分別口服(1000MLD)感染1組四週齡低NDV-HI抗體幼鴿,發現TW/99-V156b、TW/99-V157、TW/99V158和TW/84-486四株NDV分別可造成100%、60%20%和0%死亡率與其在臨床檢出的NDV-HI抗體力價GMT和CV值高低頗有正相關聯性。以上述4株WNDV病毒液混合製成之NDV不活化油質與鋁膠型疫苗,併同市售6種鴿用NDV不活化疫苗分別免疫8組,每組6隻之四週齡幼鴿,於免疫25日後再以該4株NDV混合液口服(1000 MLD)攻擊,結果該NDV不活化疫苗對幼鴿之免疫保護力顯較其他市售鴿用NDV不活化疫苗為高。選用在臨床檢測鴿血清具高抗體之高病原性新分離WNDV株製成NDV不活化疫苗可有效強化幼鴿對NDV之免疫保護力。 |
英文摘要 | Four isolates of genotype VII of velogenic viscerotropic Newcastle disease virus (WNDV) were selected on the basis of high geometric mean titer (GMT) and coefficient of variation (CV) values in sera from 10 flocks of racing pigeons; these isolates were used to inoculate 20 four-week-old pigeons (4 groups, 5 birds per group) orally with low NDV-HI titers. The mortality caused by the TW/99-V156B, TW/99-V157, TW/99-V158 and TW/84-486 isolates of WNDV was 100%, 60%, 20%, and 0%, respectively. The virulence of each isolate correlated positively with the GMT level and CV value of each isolate in assays with the above racing pigeon sera. Eight groups of 4-week-old pigeons (6 birds per group) with low NDV-HI antibody levels were immunized with either oli0emulsion or gel-type inactivated vaccines prepared with the above 4 isolates and or with one of 6 commercial inactivated NDV vaccines, then challenged orally (1000 LD50) with the mixture of the 4 homologous isolates at 25 days post vaccination. The inactivated vaccine prepared from the 4 WNDV isolates with high existing serum antibody and high virulence prominently provided higher protection levels than the commercial vaccines, and thus higher protection to pigeons. |
本系統中英文摘要資訊取自各篇刊載內容。